Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- EUR | -.--% | +0,14% | +29,68% |
2023 | Nestlé kan naar verluidt pinda-allergie therapie verkopen aan Stallergenes | CI |
2023 | Stallergenes Greer Ltd start Europese pediatrische fase III-studie met Staloral Birch | CI |
Omzet 2020 | 304 mln. 325 mln. | Omzet 2021 | 328 mln. 351 mln. | Marktkapitalisatie | 724 mln. 774 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | 33 mln. 35,28 mln. | Nettowinst (verlies) 2021 | 60 mln. 64,15 mln. | EV/omzet 2020 | 3,16 x |
Nettoschuld 2020 | 237 mln. 254 mln. | Nettoschuld 2021 | 249 mln. 266 mln. | EV/omzet 2021 | 2,97 x |
K/w-verhouding 2020 |
21,5
x | K/w-verhouding 2021 |
11,9
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 01-01-19 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 11-04-16 |
Nicola Lamacchia
BRD | Director/Board Member | - | 01-03-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 10-11-15 |
Nicola Lamacchia
BRD | Director/Board Member | - | 01-03-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,68% | 0 | |
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-21,36% | 2,34 mld. | |
-29,67% | 2,2 mld. | |
+8,38% | 1,96 mld. |